310 related articles for article (PubMed ID: 25388103)
1. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
5. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract][Full Text] [Related]
7. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
8. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
[TBL] [Abstract][Full Text] [Related]
9. Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
Janiszewska H; Styczynski J; Kolodziej B; Wysocki M; Haus O
Ann Hematol; 2009 Dec; 88(12):1193-8. PubMed ID: 19352661
[TBL] [Abstract][Full Text] [Related]
10. Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases.
Shafik RE; Abd El Wahab N; Senoun SA; Ebeid E; El Taweel MA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2263-2267. PubMed ID: 30139235
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
13. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
[TBL] [Abstract][Full Text] [Related]
14. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
Mei Y; Gao C; Wang K; Cui L; Li W; Zhao X; Liu F; Wu M; Deng G; Ding W; Jia H; Li Z
Cancer Sci; 2014 Apr; 105(4):463-72. PubMed ID: 24720529
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
Styczynski J; Piatkowska M; Jaworska-Posadzy A; Czyzewski K; Kubicka M; Kolodziej B; Kurylo-Rafinska B; Debski R; Pogorzala M; Wysocki M
Anticancer Res; 2012 Dec; 32(12):5495-9. PubMed ID: 23225457
[TBL] [Abstract][Full Text] [Related]
18. [Expression of miR-34a in Bone Marrow of Adult Acute Lymphoblastic Leukemia and Its Significance in Cell Drug Resistance].
Han B; Wang HX; Shao W; Han ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):336-40. PubMed ID: 27150988
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.
Kotani A; Ha D; Schotte D; den Boer ML; Armstrong SA; Lodish HF
Cell Cycle; 2010 Mar; 9(6):1037-42. PubMed ID: 20237425
[TBL] [Abstract][Full Text] [Related]
20. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
